United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
PLAW
Bills and Statutes
An act to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.;Improving Regulatory Transparency for New Medical Therapies Act;Public Law 114-89;
114_cong_public_laws
legislative
2016-02-11
H.R. 639, 114th Congress
H.R. 639, 114th Congress
An act to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing.
Improving Regulatory Transparency for New Medical Therapies Act
Public Law 114-89
U.S. Government Publishing Office
2015-11-25
monographic
deposited
born digital
7 digital object pages
AE 2.110:
AE 2.110/3:
AE 2.110:114-89
https://www.govinfo.gov/app/details/PLAW-114publ89
P0b002ee18e7e3622
000971728
f:publ089_114
DGPO
2016-02-11
2026-01-03
PLAW-114publ89
machine generated
eng
fdlp
PUBLIC
PLAW-114publ89
114
89
Improving Regulatory Transparency for New Medical Therapies Act
false
LEGISLATIVE HISTORY--H.R. 639:<br/><br/><br/>HOUSE REPORTS: No. 114-41, Pt. 1 (Comm. on Energy and Commerce).<br/>CONGRESSIONAL RECORD, Vol. 161 (2015):<br/> Mar. 16, considered and passed House.<br/> Oct. 26, considered and passed Senate, amended.<br/> Nov. 16, House concurred in Senate amendment.<br/><br/>
Committee on Energy and Commerce
Energy and Commerce
U.S. Government Publishing Office
2015-11-25
monographic
deposited
born digital
7 p.
AE 2.110:
AE 2.110/3:
AE 2.110:114-89
P0b002ee18e7e3622
https://www.govinfo.gov/app/details/PLAW-114publ89
f:publ089_114
Public Law 114-89
https://www.govinfo.gov/app/details/PLAW-114publ89
https://www.govinfo.gov/content/pkg/PLAW-114publ89/html/PLAW-114publ89.htm
https://www.govinfo.gov/content/pkg/PLAW-114publ89/pdf/PLAW-114publ89.pdf
https://www.govinfo.gov/content/pkg/PLAW-114publ89/uslm/PLAW-114publ89.xml
fdlp
DGPO
2016-02-11
2026-01-03
PLAW-114publ89
machine generated
eng
PUBLIC
PLAW-114publ89
114
89
Improving Regulatory Transparency for New Medical Therapies Act
false
LEGISLATIVE HISTORY--H.R. 639:<br/><br/><br/>HOUSE REPORTS: No. 114-41, Pt. 1 (Comm. on Energy and Commerce).<br/>CONGRESSIONAL RECORD, Vol. 161 (2015):<br/> Mar. 16, considered and passed House.<br/> Oct. 26, considered and passed Senate, amended.<br/> Nov. 16, House concurred in Senate amendment.<br/><br/>
Committee on Energy and Commerce
Energy and Commerce
United States House Bill 639 (114th Congress)
H.R. 639
114
side note
United States House Bill 639 (114th Congress)
H.R. 639
114
legislative history
United States Code
Title 21 Section 355
Title 21 Section 360b
Title 21 Section 360ccc-1
Title 21 Section 360ccc-2(c)
Title 21 Section 360ccc(d)
Title 21 Section 811
Title 21 Section 823
Title 21 Section 953
21 U.S.C. 355
21 U.S.C. 360b
21 U.S.C. 360ccc-1
21 U.S.C. 360ccc-2(c)
21 U.S.C. 360ccc(d)
21 U.S.C. 811
21 U.S.C. 823
21 U.S.C. 953
United States Code
Title 35 Section 156
35 U.S.C. 156
United States Code
Title 42 Section 262
42 U.S.C. 262
United States Statutes at Large
Volume 129 Page 698
Volume 129 Page 699
Volume 129 Page 700
Volume 129 Page 701
Volume 129 Page 702
Volume 129 Page 703
129 Stat. 698
129 Stat. 699
129 Stat. 700
129 Stat. 701
129 Stat. 702
129 Stat. 703
United States House Report 41 (114th Congress)
H. Rept. 114-41
Pt. 1